MOUNTAIN VIEW, Calif., Sept. 26 /PRNewswire/ -- Aviron (Nasdaq: AVIR)
today announced the appointments of Ed Arcuri, Ph.D., senior vice president,
operations, to the newly created position of senior vice president and chief
operating officer and Carol Olson, senior vice president, commercial
development, to the newly created position of senior vice president and chief
commercial officer.
Dr. Arcuri adds oversight for the quality assurance, quality control and
regulatory affairs organizations to his existing manufacturing and operational
responsibilities. Ms. Olson's responsibilities for corporate development,
commercialization, information technology and marketing remain unchanged.
The company also announced the promotion of Michael Cowan to vice
president, compliance. Previously, Mr. Cowan was senior director, quality
assurance and validation. In this newly created position, Mr. Cowan will
report directly to the chief executive officer and will oversee the company's
compliance with all applicable current good manufacturing practices and
regulatory requirements.
"By continuing our commitment to build and refine our infrastructure, we
are taking additional steps in our transition from a development-stage company
to a commercial organization," said C. Boyd Clarke, Aviron chairman and chief
executive officer.
Aviron is a biopharmaceutical company based in Mountain View, California,
focused on the prevention of disease through innovative vaccine technology.
Additional information about the company, including recent press releases,
can be located at http://www.aviron.com .
SOURCE Aviron
 back to top
Related links:
http://www.aviron.com
Company News On-Call:
http://www.prnewswire.com/comp/114000.html
CONTACT:
media, John Bluth of Aviron, +1-650-919-3716;
or Ben Butkus of Fleishman-Hillard, +1-212-453-2000, for Aviron;
or investors, John Bluth, +1-650-919-3716, or Fred Kurland,
+1-650-919-6666, both of Aviron
|
